EP-104IAR Phase 1 study results published in Osteoarthritis and Cartilage Open Company continues to expand its patent estate for EP-104IAR with patent grant in Israel VICTORIA, BC – Eupraxia Pharmaceuticals… Read More
VANCOUVER, BC – Satisfai Health, a leading medical solutions provider specializing in artificial intelligence (AI) applications, particularly in Gastrointestinal Endoscopy, has acquired an exclusive global license from the University of Augsburg… Read More
VANCOUVER, BC – Bold Therapeutics, a clinical-stage biopharmaceutical company developing BOLD-100, a first-in-class anti-resistance oncology therapeutic, has demonstrated potent anti-tumor activity in combination with a PD-1 checkpoint inhibitor in a validated… Read More
Canadian granting agency MITACS commits to three years of funding for the project’s second stage to optimize certain proprietary microcarrier technologies for use in RepliCel’s cell therapy manufacturing RepliCel signs… Read More
Data fragmentation and a lack of transparency are serious problems in healthcare. A unified overview of a patient’s status (including at home) would assist collaboration within hospitals and reduce costs… Read More
